Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Ilhan

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Medical Oncology and Tumor Pharmacotherapy|January 1, 1992
P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocolsM Beksaç, H Akan, H Koç, et al.
Blood|September 15, 1996
Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation?H Koc, G Gürman, O Arslan, et al.
Haematologia|January 1, 1997
Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphomaI Aydogdu, H Koc, O Ilhan, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 31, 1999
Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case reportC Ustün, H Celebi, M Arat, et al.
Blood|September 1, 1995
HLA-DR frequency in Turkish aplastic anemia patients and the impact of HLA-DR2 positivity in response rate in patients receiving immunosuppressive therapyO Ilhan, M Beksaç, H Koç, et al.
Journal of Chemotherapy (Florence, Italy)|November 28, 1997
Allogeneic peripheral blood stem cell transplantation: is there an increased risk of graft vs host disease in leukemia patients?H Koç, G Gürman, O Arslan, et al.
Haematologia|August 15, 1998
Incidence of tuberculosis after bone marrow transplantation in a single center from TurkeyO Arslan, G Gürman, I Dilek, et al.
Transplantation Proceedings|June 4, 2015
Hyperviscosity in renal transplant recipientsE Tutal, M Erkmen Uyar, S Uyanik, et al.
Bone Marrow Transplantation|September 9, 2004
High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma -- a retrospective evaluationT Demirer, M Ayli, T Fen, et al.
Transfusion Science|January 6, 2000
The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantationO Ilhan, O Arslan, M Arat, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Medical Oncology and Tumor Pharmacotherapy|January 1, 1992
P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocolsM Beksaç, H Akan, H Koç, et al.
Blood|September 15, 1996
Is there an increased risk of graft-versus-host disease after allogeneic peripheral blood stem cell transplantation?H Koc, G Gürman, O Arslan, et al.
Haematologia|January 1, 1997
Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphomaI Aydogdu, H Koc, O Ilhan, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 31, 1999
Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: a case reportC Ustün, H Celebi, M Arat, et al.
Blood|September 1, 1995
HLA-DR frequency in Turkish aplastic anemia patients and the impact of HLA-DR2 positivity in response rate in patients receiving immunosuppressive therapyO Ilhan, M Beksaç, H Koç, et al.
Journal of Chemotherapy (Florence, Italy)|November 28, 1997
Allogeneic peripheral blood stem cell transplantation: is there an increased risk of graft vs host disease in leukemia patients?H Koç, G Gürman, O Arslan, et al.
Haematologia|August 15, 1998
Incidence of tuberculosis after bone marrow transplantation in a single center from TurkeyO Arslan, G Gürman, I Dilek, et al.
Transplantation Proceedings|June 4, 2015
Hyperviscosity in renal transplant recipientsE Tutal, M Erkmen Uyar, S Uyanik, et al.
Bone Marrow Transplantation|September 9, 2004
High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lymphoma -- a retrospective evaluationT Demirer, M Ayli, T Fen, et al.
Transfusion Science|January 6, 2000
The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantationO Ilhan, O Arslan, M Arat, et al.
Pageof 8